MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G, Quintavalle C, Donnarumma E, Puoti I, Diaz-Lagares A, Iaboni M, Fiore D, Russo V, Todaro M, Romano G, Thomas R, Cortino G, Gaggianesi M, Esteller M, Croce CM, Condorelli G.
Roscigno G, et al.
Oncotarget. 2016 Jan 5;7(1):580-92. doi: 10.18632/oncotarget.5979.
Oncotarget. 2016.
PMID: 26556862
Free PMC article.